Efficacy of Nitazoxanide against Cryptosporidium parvum in Cell Culture and in Animal Models
Nitazoxanide (NTZ), a drug currently being tested in human clinical trials for efficacy against chronic cryptosporidiosis, was assessed in cell culture and in two animal models. The inhibitory activity of NTZ was compared with that of paromomycin (PRM), a drug that is partially effective against Cry...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1998
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105716/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9687390/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.8.1959 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|